MLICM
EVLV icon

Metropolitan Life Insurance Company (MetLife)’s Evolv Technologies EVLV Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EVLV Stock Details EVLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,582
Closed -$20.4K – 714
2024
Q1 		$20.4K Sell
4,582
-1,675
-27% -$7.24K ﹤0.01% 1858
2023
Q4 		$29.5K Hold
6,257
– – ﹤0.01% 1732
2023
Q3 		$30.4K Hold
6,257
– – ﹤0.01% 1671
2023
Q2 		$37.5K Buy
6,257
+3,496
+127% +$16.5K ﹤0.01% 1596
2023
Q1 		$8.61K Sell
2,761
-2,930
-51% -$8.37K ﹤0.01% 2210
2022
Q4 		$14.7K Hold
5,691
– – ﹤0.01% 2137
2022
Q3 		$12.1K Hold
5,691
– – ﹤0.01% 2253
2022
Q2 		$15.1K Buy
+5,691
New +$15.1K ﹤0.01% 2177

Other funds holding EVLV

GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
KCM
Key Colony Management Little Rock, Arkansas $73.7M AUM 49.85% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EVLV Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Evolv Technologies (EVLV) in Q2 2024, closing a stake of 4,582 shares — an estimated $20.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EVLV in Q2 2022 and held it in 8 quarters. The position peaked at $37.5K in Q2 2023. 162 funds tracked by Wall St. Rank hold EVLV as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Evolv Technologies position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,582 Evolv Technologies shares in Q2 2024, an estimated $20.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Evolv Technologies in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Evolv Technologies position peaked at $37.5K in Q2 2023.
  • 162 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.